CORCEPT THERAPEUTICS INC (CORT) Insider Trading -- Recent Executive & Director Transactions
14 insiders reported 435 Form 4 transactions for CORCEPT THERAPEUTICS INC (CORT) over the past 18 months (most recent 2026-10-05). Recent activity: Maduck Sean (President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission) Buy 413 shares, Lyon Joseph Douglas (Chief Accounting & Technology Officer) Buy 810 shares, Vieira Roberto Wandenkolk (President, Oncology) Buy 8,333 shares, Maduck Sean (President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission) Sell 413 shares, Lyon Joseph Douglas (Chief Accounting & Technology Officer) Sell 810 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Maduck Sean | President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission | Buy | 413 | $3,416 |
| 2026-10-05 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Buy | 810 | $10,984 |
| 2026-10-05 | Vieira Roberto Wandenkolk | President, Oncology | Buy | 8,333 | $180,243 |
| 2026-10-05 | Maduck Sean | President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission | Sell | 413 | $47,717 |
| 2026-10-05 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Sell | 810 | $93,473 |
| 2026-10-05 | Vieira Roberto Wandenkolk | President, Oncology | Sell | 1,100 | $125,973 |
| 2026-10-05 | Maduck Sean | President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission | Buy | 24,587 | $203,334 |
| 2026-10-05 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Buy | 3,357 | $45,521 |
| 2026-10-05 | Vieira Roberto Wandenkolk | President, Oncology | Sell | 2,086 | $241,412 |
| 2026-10-05 | Maduck Sean | President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission | Sell | 15,843 | $1.8M |
| 2026-10-05 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Buy | 5,833 | $112,344 |
| 2026-10-05 | Vieira Roberto Wandenkolk | President, Oncology | Sell | 5,147 | $600,063 |
| 2026-10-05 | Maduck Sean | President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission | Sell | 8,744 | $1.0M |
| 2026-10-05 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Sell | 4,446 | $514,389 |
| 2026-10-05 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Sell | 4,744 | $552,869 |
| 2026-09-28 | Robb Gary Charles | Chief Business Officer | Sell | 17,100 | $0 |
| 2026-09-28 | Robb Gary Charles | Chief Business Officer | Buy | 5,000 | $0 |
| 2026-09-28 | Robb Gary Charles | Chief Business Officer | Buy | 5,000 | $0 |
| 2026-09-18 | Robb Gary Charles | Chief Business Officer | Buy | 17,493 | $144,667 |
| 2026-09-18 | Vieira Roberto Wandenkolk | President, Oncology | Sell | 296 | $29,843 |
| 2026-09-16 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Buy | 2,596 | $29,465 |
| 2026-09-16 | WILSON JAMES N | Director | Sell | 6,800 | $749,835 |
| 2026-09-16 | WILSON JAMES N | Director | Sell | 400 | $44,335 |
| 2026-09-16 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Buy | 7,404 | $100,398 |
| 2026-09-16 | WILSON JAMES N | Director | Sell | 2,800 | $312,771 |
Source: SEC Form 4 filings · as of 2026-10-05